Xponential Fitness Q4 revenue USD 83.0 million down 26% Adjusted EBITDA to USD 22.9 million

Reuters
02/27
<a href="https://laohu8.com/S/XPOF">Xponential Fitness</a> Q4 revenue USD 83.0 million down 26% Adjusted EBITDA to USD 22.9 million

Xponential (XPOF) reported Q4 FY 2025 revenue of USD 83.0 million and a net loss of USD 45.6 million, with Adjusted EBITDA of USD 22.9 million. North America system-wide sales in Q4 were USD 446.7 million (+5.0%), while North America same store sales fell 4% and quarterly run-rate average unit volume (AUV) was USD 683,000. For FY 2025, Xponential posted revenue of USD 314.9 million (-2.0%), a net loss of USD 53.7 million, and Adjusted EBITDA of USD 111.8 million. North America system-wide sales were USD 1.75 billion (+13.0%) and North America same store sales rose 0.5%. The company said it sold 179 franchise licenses and opened 341 gross new studios in 2025. Xponential highlighted regulatory and legal updates, including an agreement to pay USD 17.0 million over 12 months to resolve the previously disclosed FTC investigation, subject to approvals, and a finalized USD 22.75 million settlement with over 500 current and former franchisees to be paid over 35 months. For 2026, it guided to revenue of USD 260.0 million to USD 270.0 million and Adjusted EBITDA of USD 100.0 million to USD 110.0 million, with net new studio openings expected at 150 to 170 and North America system-wide sales of USD 1.72 billion to USD 1.80 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xponential Fitness Inc. published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10